DK1824493T3 - Oral suspension, der omfatter meloxicam - Google Patents

Oral suspension, der omfatter meloxicam

Info

Publication number
DK1824493T3
DK1824493T3 DK05850431T DK05850431T DK1824493T3 DK 1824493 T3 DK1824493 T3 DK 1824493T3 DK 05850431 T DK05850431 T DK 05850431T DK 05850431 T DK05850431 T DK 05850431T DK 1824493 T3 DK1824493 T3 DK 1824493T3
Authority
DK
Denmark
Prior art keywords
meloxicam
oral suspension
pain
acute
preparation
Prior art date
Application number
DK05850431T
Other languages
Danish (da)
English (en)
Inventor
Caspar Peter Elisabeth Biesmans
Spiegeleer Bart De
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34929998&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1824493(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of DK1824493T3 publication Critical patent/DK1824493T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
DK05850431T 2004-12-06 2005-12-02 Oral suspension, der omfatter meloxicam DK1824493T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04106318 2004-12-06
PCT/EP2005/056419 WO2006061351A1 (en) 2004-12-06 2005-12-02 Oral suspension comprising meloxicam

Publications (1)

Publication Number Publication Date
DK1824493T3 true DK1824493T3 (da) 2008-12-08

Family

ID=34929998

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05850431T DK1824493T3 (da) 2004-12-06 2005-12-02 Oral suspension, der omfatter meloxicam

Country Status (14)

Country Link
US (1) US7705000B2 (pl)
EP (1) EP1824493B1 (pl)
JP (1) JP2008523024A (pl)
AT (1) ATE404206T1 (pl)
AU (1) AU2005313365A1 (pl)
CA (1) CA2586288A1 (pl)
DE (1) DE602005009016D1 (pl)
DK (1) DK1824493T3 (pl)
ES (1) ES2313452T3 (pl)
NO (1) NO20073419L (pl)
PL (1) PL1824493T3 (pl)
PT (1) PT1824493E (pl)
TW (1) TW200635598A (pl)
WO (1) WO2006061351A1 (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
GB2438287A (en) * 2006-05-19 2007-11-21 Norbrook Lab Ltd Stable aqueous suspension
EP2034958B1 (en) * 2006-05-19 2009-10-28 Norbrook Laboratories Limited Stable aqueous suspension having palatable taste
WO2008009664A2 (en) * 2006-07-19 2008-01-24 Boehringer Ingelheim International Gmbh Treatment of pain
FR2911506B1 (fr) * 2007-01-18 2009-07-03 Ceva Sante Animale Sa Compositions pharmaceutiques destinees a une administration par voie orale sous forme de suspensions aqueuses stabilisees
US8999395B2 (en) 2007-02-09 2015-04-07 Ceva Sante Animale Pharmaceutical compositions for oral administration in the form of stabilised aqueous suspensions
US20150231156A1 (en) * 2007-11-13 2015-08-20 Meritage Pharma, Inc. Corticosteroid compositions
WO2010025491A1 (en) * 2008-09-05 2010-03-11 Troy Laboratories Pty Limited Treatment of neonate foals with meloxicam
JP5559339B2 (ja) * 2009-10-12 2014-07-23 ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング メロキシカムを含む組成物のための容器
GB201006218D0 (en) * 2010-04-14 2010-06-02 Ayanda As Composition
GB201117858D0 (en) * 2011-10-17 2011-11-30 Norbrook Lab Ltd Paste
PL239019B1 (pl) * 2017-07-14 2021-10-25 Aflofarm Farm Polska Spolka Z Ograniczona Odpowiedzialnoscia Kompozycja farmaceutyczna w postaci wodnego roztworu, korzystnie syropu, zawierająca pranobeks inozyny oraz glukonianu cynku oraz jej sposób otrzymywania
KR20200046018A (ko) * 2017-08-24 2020-05-06 지앙수 헨그루이 메디슨 컴퍼니 리미티드 멜록시캄을 함유하는 주사용 약학 조성물 및 그 제조 방법
JP7374501B2 (ja) * 2018-05-11 2023-11-07 南京清普生物科技有限公司 メロキシカム組成物、製剤及びその製造方法と応用
EA202190045A1 (ru) * 2018-06-15 2021-03-17 Янссен Фармацевтика Нв Составы/композиции, содержащие ибрутиниб
GB2585825B (en) * 2019-07-09 2023-03-22 Lexon Uk Holdings Ltd Suspending vehicle formulation
KR102530032B1 (ko) 2019-09-18 2023-05-09 정원구 반려동물용 현탁액 조성물 및 이의 제조방법
CN113143863A (zh) * 2020-01-22 2021-07-23 浙江贝灵生物医药有限公司 一种口服溶媒组合物及其制备方法与应用
CN112587497A (zh) * 2020-12-25 2021-04-02 苏州中化药品工业有限公司 一种美洛昔康混悬液胶囊剂及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ234143A (en) 1989-06-28 1991-10-25 Mcneil Ppc Inc Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
US5272137A (en) 1992-02-14 1993-12-21 Mcneil-Pfc, Inc. Aqueous pharmaceutical suspension for pharmaceutical actives
IT1286496B1 (it) * 1996-11-20 1998-07-15 Leetrim Ltd Dublin Composizione farmaceutica orale ad attivita' antipiretica,analgesica ed antiinfiammatoria
AU750125B2 (en) * 1997-08-27 2002-07-11 Hexal Ag New pharmaceutical compositions of meloxicam with improved solubility and bioavailability
EP0945134A1 (de) 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation
EP0945131A1 (de) * 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG Perorale Wirkstoff-Suspension
WO1999059634A1 (fr) * 1998-05-15 1999-11-25 Wakamoto Pharmaceutical Co., Ltd. Gouttes oculaires anti-inflammatoires
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
ES2348710T5 (es) * 2001-06-01 2014-02-17 Pozen, Inc. Composiciones farmacéuticas para el suministro coordinado de NSAID
US7666876B2 (en) * 2002-03-19 2010-02-23 Vernalis (R&D) Limited Buprenorphine formulations for intranasal delivery
JP2004131495A (ja) * 2002-09-17 2004-04-30 Nippon Boehringer Ingelheim Co Ltd 非ステロイド系抗炎症剤の局所送達用医薬組成物
US20050095299A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions

Also Published As

Publication number Publication date
ATE404206T1 (de) 2008-08-15
TW200635598A (en) 2006-10-16
ES2313452T3 (es) 2009-03-01
PT1824493E (pt) 2008-11-18
JP2008523024A (ja) 2008-07-03
CA2586288A1 (en) 2006-06-15
PL1824493T3 (pl) 2009-01-30
EP1824493A1 (en) 2007-08-29
NO20073419L (no) 2007-07-03
US20090221563A1 (en) 2009-09-03
EP1824493B1 (en) 2008-08-13
WO2006061351A1 (en) 2006-06-15
AU2005313365A1 (en) 2006-06-15
DE602005009016D1 (de) 2008-09-25
US7705000B2 (en) 2010-04-27

Similar Documents

Publication Publication Date Title
DK1824493T3 (da) Oral suspension, der omfatter meloxicam
HRP20110969T1 (en) Pimobendan to be used for the reduction of heart size in mammals suffering from heart failure
MXPA06014510A (es) Composiciones y metodos para tratar trastornos inflamatorios.
MY143407A (en) Indazole derivatives as inhibitors of hormone sensitive lipase
IS8349A (is) 2,4-pýrimídíndíamín gagnleg í meðhöndlun æxlissjúkdóma, bólgu- og ónæmiskerfissjúkdóma
DE602005017753D1 (de) Mittel für die transdermale verabreichung von nikotin
CY1112320T1 (el) Τιτλοδοτηση της ταπενταδολης
EP1888091A4 (en) USE OF MAIN OLEOCANTHAL IRRIGATION IN OLIVE OIL AND STRUCTURALLY AND FUNCTIONALLY SIMILAR COMPONENTS
EP2262778B8 (en) 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40
TW200509896A (en) Analeptic and drug combinations
EE05357B1 (et) Tablett, mis sisaldab v„hemalt kahte eristatavat segmenti, ning selle kasutamine
HRP20050579B1 (hr) Nove sinergistiäśne kombinacije koje sadrže roflumilast i formoterol
TWI372047B (en) Topical pain relief compositions of n,2,3-trimethyl-2-isopropylbutamide and methods for using the same
ATE460415T1 (de) Therapeutische pyrazoloä3,4-büpyridine und - indazole
ITMI20050417A1 (it) Uso di farmaci anti-infiammatori non steroidei per via inalatoria nella terapia della bronchite acuta e cronica
WO2005113814A3 (en) Biomarkers of chronic pelvic pain syndrome
EA200900575A1 (ru) Композиция, содержащая антагонист рецептора nk1 и ssri, для лечения шума в ушах и потери слуха
EA200801890A1 (ru) Средство для лечения шума в ушах
WO2010129788A3 (en) Uses of cationic hydroxythylcellulose in oral ingestion forms, and prevention and treatment of metabolic disorders
NO20065473L (no) IL-6RL/IL-6-kimaerer for terapi av kjemoterapeutisk indusert perifer nevropati.
MY150436A (en) 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof
MXPA04000418A (es) Tratamiento de dolor cronico con 3-heterocicloxi- y -cicloalquiloxi-3-fenilpropanaminas.
SE0300988D0 (sv) New use
ITFI20060002U1 (it) "onivades" sedia che si trasforma in tavolino e viceversa.
TH0701005261A (th) แอนติ-Notch3 อะโกนิสต์ แอนติบอดีตัวใหม่และการใช้งานในการป้องกันและการบำบัดโรคที่เกี่ยวข้องกับ Notch3